Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : The Trump Presidency -- Ignore unavailable to you. Want to Upgrade?

To: J_F_Shepard who wrote (192777)	1/30/2021 9:38:03 PM
From: bentway	Read Replies (2) \| Respond to of 361483

>>In a July 23 opinion piece in Newsweek, Risch argued for the use of hydroxychloroquine, in combination with the antibiotic azithromycin, to treat high-risk COVID-19 patients without waiting for further testing on the effectiveness of the treatment.<< Hey, he had this 'scientific paper' published in that highly respected epidemiological journal, Newsweek! As you've noted, many scientists 'reviewed' it and called it bullshit, which it is. You know how he voted.

To: J_F_Shepard who wrote (192777)	1/30/2021 9:54:03 PM
From: i-node	1 Recommendation Recommended By Maple MAGA Read Replies (1) \| Respond to of 361483

You can't just say "it is highly disputed". That's not how science works. Dispute it if you have something. Harvey Reisch is one of many. He just happens to be the guy who compiled a ton of studies. Have you ever once tried to find studies that found HCQ to be effective? Here's one for you. I'm very sure you know HCQ is widely used in Africa and South America. India has one of the lowest per capita death rates and they carry it around like aspirin. Seems Asian countries find it to be extremely beneficial. Asian Countries